NewcelX Ltd. (NCEL) Live Share Price, Invest From India

NewcelX Ltd. Stock Performance

as on June 27, 2026 at 2:16 pm IST

Day's Low
Day's High
$3.46
Day's Price Range
$3.80
$3.64
4.95%
Downside
4.40%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$3.64
100.00%
Downside
-100.00%
Upside

NewcelX Ltd. share price movements today

Previous Close: $3.55
Open: $3.46
Volume: 186.1K
Day's Low - High: $3.46 - $3.80

NewcelX Ltd. Historical Returns

1 Month Return: + 12.7 %
3 Month Return: + 43.72 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

NewcelX Ltd. Stock Fundamentals & Key Indicators

Check NewcelX Ltd. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$19.0M

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

NewcelX Ltd. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of NewcelX Ltd. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
NewcelX Ltd.	NA	$19.0M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$39.3B	67.15%	74.07	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$120.6B	147.08%	28.17	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$65.4B	12.64%	15.22	29.65%	0.58%

Indian Investors' Interest in NewcelX Ltd. Stock

Search interest for NewcelX Ltd. Stock has increased by 50% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 29, 2026 to June 28, 2026

Change:50% versus previous 30 day period

NewcelX Ltd. Quarterly Profit & Loss

All numbers in Millions USD


Total Revenue
Gross Profit
Operating Income
EBITDA
Interest Expense
Depreciation
Income Before Tax
Income Tax Expense
Net Income
Net Profit Margin

NewcelX Ltd. Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-
Gross Profit	0	0	0	0	-
Operating Income	-11	-15	-11	-4	-2
EBITDA	-11	-15	-11	-3	-
Interest Expense	0	0	0	0	6
Depreciation	1	1	2	1	0
Income Before Tax	-11	-16	-12	-1	-8
Income Tax Expense	0	0	0	0	-
Net Income	-3	-4	-3	0	-8
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

NewcelX Ltd. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2021	Dec 2021	Sep 2022	Mar 2023	Jun 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025
Net Income	-4	-7	-8	-7	-7	0	-2	0	-2
Operating Cash Flow	-9	-5	-7	-6	-7	-2	-1	-2	-2
Investing Cash Flow	0	0	4	-7	-	-	-	0	-
Financing Cash Flow	16	3	3	13	-	1	1	3	3
Change in Cash	6	-1	-4	7	-7	0	0	1	1

NewcelX Ltd. Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-5	-5	-2	-11	-16	-12	-1	-8
Operating Cash Flow	-2	0	0	-14	-13	-9	-4	-2
Investing Cash Flow	-	0	0	0	-3	-	0	-
Financing Cash Flow	0	0	0	20	17	1	5	2
Change in Cash	-2	0	0	5	3	-8	0	1

Global Institutional Holdings in NewcelX Ltd.

Funds	Holdings
UBS Group AG	0.01%
Tower Research Capital LLC	0%
CoreCap Advisors, LLC	0%

Insights on NewcelX Ltd.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, NCEL has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 7 days, NCEL stock has moved up by 10.0%
NO EFFECT
Against Peers
In the last 3 years, NewcelX Ltd. Ordinary Shares has experienced a drawdown of -90.8%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 79.2%

About NewcelX Ltd.

NewcelX Ltd., a biopharmaceutical company, engages in developing transformative stem-cell-derived therapies for Diabetes. The company develops NCEL-101, a cellular therapy product based on enriched pancreatic islet-like clusters for the treatment of Type 1 diabetes and Type 2 insulin dependent diabetes; AstroRx, an off-the-shelf cryopreserved cell therapy product for the treatment of Amyotrophic Lateral Sclerosis and neurodegenerative indications; and Dual Orexin-Receptor Agonist (DOXA), a small molecules platform for the treatment of sleep disorders, Neurodegenerative/ neuroinflammation diseases, and Diabetes Associated Neurological Disorders. It also develops iTOL-102, NCEL-201, NCEL-301, and NCEL-007. NewcelX Ltd. was founded in 2008 and is headquartered in Kloten, Switzerland.

Organisation	NewcelX Ltd.
Headquarters	Hohstrasse 1, Kloten, Switzerland, 8302
Industry	Biotechnology
CEO	Mr. Ronen Twito CPA
E-voting on shares	Click here to vote

Key Management of NewcelX Ltd.

Name	Title
Mr. Yossi Ben-Yossef	Honorary President & Strategic Consultant
Prof. Ariel Revel M.D.	Director of Medical Affairs
Mr. Ronen Twito CPA	CEO & Executive Chairman
Prof. Michel Revel M.D., Ph.D.	Co-Founder, Chief Scientist, Head of the Scientific Advisory Board & Director
Mr. Omri Hagai	Chief Financial Officer
Mr. Alexander C. Zwyer M.B.A.	Chief Business Officer & Executive Director
Dr. Eric Konofal M.D., Ph.D.	Head of Doxa Program

FAQs

What is NewcelX Ltd. share price today?

NewcelX Ltd. share price today is $3.64 as on June 27, 2026 at 8:46 am IST at the close of the market. NewcelX Ltd. share today touched a day high of $3.8 and a low of $3.46.

What is the 52 week high and 52 week low for NewcelX Ltd. share?

NewcelX Ltd. share touched a 52 week high of $0 on January 1, 1970 and a 52 week low of $0 on January 1, 1970. NewcelX Ltd. stock price today i.e. June 27, 2026 at 8:46 am IST is closed at $3.64,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is NewcelX Ltd.'s market capitalisation today?

NewcelX Ltd. market capitalisation is $0.00T as on June 27, 2026 at 8:46 am IST.

How to invest in NewcelX Ltd. Stock (NCEL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for NewcelX Ltd. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in NewcelX Ltd. Shares that will get you 0.4121 shares as per NewcelX Ltd. share price of $3.64 per share as on June 27, 2026 at 8:46 am IST.

What is the minimum amount required to buy NewcelX Ltd. Stock (NCEL) from India?

Indian investors can start investing in NewcelX Ltd. (NCEL) shares with as little as ₹94.3 or $1 (as of June 28, 2026 at 1:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in NewcelX Ltd. stock (as per the Rupee-Dollar exchange rate as on June 28, 2026 at 1:37 am IST). Based on NewcelX Ltd. share’s latest price of $3.64 as on June 27, 2026 at 8:46 am IST, you will get 2.7473 shares of NewcelX Ltd.. Learn more about fractional shares .